SELECT MEDICAL HOLDINGS CORP (SEM) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:SEM • US81619Q1058

15.08 USD
0 (0%)
At close: Feb 3, 2026
15.08 USD
0 (0%)
After Hours: 2/3/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, SEM scores 4 out of 10 in our fundamental rating. SEM was compared to 102 industry peers in the Health Care Providers & Services industry. While SEM is still in line with the averages on profitability rating, there are concerns on its financial health. SEM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SEM was profitable.
  • SEM had a positive operating cash flow in the past year.
  • Each year in the past 5 years SEM has been profitable.
  • Each year in the past 5 years SEM had a positive operating cash flow.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • SEM has a better Return On Assets (3.72%) than 67.65% of its industry peers.
  • SEM has a Return On Equity of 12.53%. This is in the better half of the industry: SEM outperforms 77.45% of its industry peers.
  • SEM's Return On Invested Capital of 4.34% is in line compared to the rest of the industry. SEM outperforms 50.98% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SEM is significantly below the industry average of 9.16%.
  • The 3 year average ROIC (3.10%) for SEM is below the current ROIC(4.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROIC 4.34%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With a decent Profit Margin value of 4.08%, SEM is doing good in the industry, outperforming 75.49% of the companies in the same industry.
  • SEM's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 5.17%, SEM is doing good in the industry, outperforming 64.71% of the companies in the same industry.
  • SEM's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 12.22%, SEM is doing worse than 70.59% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SEM has declined.
Industry RankSector Rank
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

More info and screens

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SEM is destroying value.
  • Compared to 1 year ago, SEM has more shares outstanding
  • SEM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SEM has been reduced compared to a year ago.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • SEM has an Altman-Z score of 1.57. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
  • SEM has a Altman-Z score (1.57) which is comparable to the rest of the industry.
  • SEM has a debt to FCF ratio of 10.18. This is a negative value and a sign of low solvency as SEM would need 10.18 years to pay back of all of its debts.
  • SEM has a Debt to FCF ratio of 10.18. This is comparable to the rest of the industry: SEM outperforms 45.10% of its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that SEM has dependencies on debt financing.
  • SEM's Debt to Equity ratio of 1.03 is on the low side compared to the rest of the industry. SEM is outperformed by 62.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Altman-Z 1.57
ROIC/WACC0.43
WACC10.04%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM's Current ratio of 1.09 is on the low side compared to the rest of the industry. SEM is outperformed by 63.73% of its industry peers.
  • A Quick Ratio of 1.09 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a Quick ratio (1.09) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

  • The earnings per share for SEM have decreased strongly by -59.81% in the last year.
  • The Earnings Per Share has been growing slightly by 5.88% on average over the past years.
  • Looking at the last year, SEM shows a small growth in Revenue. The Revenue has grown by 7.48% in the last year.
  • SEM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.00% yearly.
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%

3.2 Future

  • SEM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.83% yearly.
  • The Revenue is expected to decrease by -2.85% on average over the next years.
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.53, SEM is valued on the expensive side.
  • Based on the Price/Earnings ratio, SEM is valued a bit cheaper than the industry average as 77.45% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 28.18. SEM is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 11.39 indicates a reasonable valuation of SEM.
  • 85.29% of the companies in the same industry are more expensive than SEM, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of SEM to the average of the S&P500 Index (25.51), we can say SEM is valued rather cheaply.
Industry RankSector Rank
PE 17.53
Fwd PE 11.39
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 76.47% of the companies in the same industry are more expensive than SEM, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a rather cheap valuation: SEM is cheaper than 84.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.73
EV/EBITDA 8.56
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • SEM has a very decent profitability rating, which may justify a higher PE ratio.
  • SEM's earnings are expected to decrease with -2.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.98
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%

More info and screens

5

5. Dividend

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.47, SEM pays a better dividend. On top of this SEM pays more dividend than 88.24% of the companies listed in the same industry.
  • SEM's Dividend Yield is comparable with the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • SEM has paid a dividend for at least 10 years, which is a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • SEM pays out 18.80% of its income as dividend. This is a sustainable payout ratio.
DP18.8%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (2/3/2026, 8:04:00 PM)

After market: 15.08 0 (0%)

15.08

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners82.91%
Inst Owner Change-2.29%
Ins Owners11.06%
Ins Owner Change0.26%
Market Cap1.87B
Revenue(TTM)5.19B
Net Income(TTM)211.72M
Analysts77.78
Price Target18.53 (22.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP18.8%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.01%
Min EPS beat(2)30.21%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)-20.63%
Min EPS beat(4)-158.51%
Max EPS beat(4)49.82%
EPS beat(8)4
Avg EPS beat(8)-7.1%
EPS beat(12)7
Avg EPS beat(12)-2.62%
EPS beat(16)9
Avg EPS beat(16)-3.49%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-3.63%
Min Revenue beat(4)-11.07%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.53%
Revenue beat(12)7
Avg Revenue beat(12)-0.91%
Revenue beat(16)10
Avg Revenue beat(16)5.68%
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.03%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)6.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 17.53
Fwd PE 11.39
P/S 0.36
P/FCF 10.73
P/OCF 4.58
P/B 1.11
P/tB N/A
EV/EBITDA 8.56
EPS(TTM)0.86
EY5.7%
EPS(NY)1.32
Fwd EY8.78%
FCF(TTM)1.41
FCFY9.32%
OCF(TTM)3.29
OCFY21.83%
SpS41.89
BVpS13.64
TBVpS-6.02
PEG (NY)N/A
PEG (5Y)2.98
Graham Number16.25
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROCE 5.65%
ROIC 4.34%
ROICexc 4.39%
ROICexgc 9.14%
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
FCFM 3.35%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
ROICexc(3y)3.14%
ROICexc(5y)4.99%
ROICexgc(3y)6.3%
ROICexgc(5y)12.6%
ROCE(3y)4.06%
ROCE(5y)6.32%
ROICexgc growth 3Y-27.06%
ROICexgc growth 5Y-9.65%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-5.51%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
F-Score5
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Debt/EBITDA 4.17
Cap/Depr 155.87%
Cap/Sales 4.5%
Interest Coverage 2.17
Cash Conversion 97.47%
Profit Quality 82.19%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.57
F-Score5
WACC10.04%
ROIC/WACC0.43
Cap/Depr(3y)103.75%
Cap/Depr(5y)94.3%
Cap/Sales(3y)4.39%
Cap/Sales(5y)3.74%
Profit Quality(3y)115.02%
Profit Quality(5y)150.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A
EBIT growth 1Y0.4%
EBIT growth 3Y-27.83%
EBIT growth 5Y-10.68%
EBIT Next Year-15.98%
EBIT Next 3Y-1.14%
EBIT Next 5YN/A
FCF growth 1Y-9.04%
FCF growth 3Y10.24%
FCF growth 5Y0.52%
OCF growth 1Y-1.83%
OCF growth 3Y8.88%
OCF growth 5Y3.07%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 6 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 17.53 and the Price/Book (PB) ratio is 1.11.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.